Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Michael Schreinlechner

Medical University of Innsbruck

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cardiology

100%

Medical Imaging

20%

Cardiac Imaging

40%

Hypercholesterolemia

40%

Atherosclerosis

30%

Cardiometabolic Health

20%

Vascular Biology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Exercise-Induced Fluid Retention, Cardiac Volume Overload, and Peripheral Edema in Ultra-Distance Cyclists

Article Link

Year:

2024

Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial

Article Link

Year:

2024

Hepatocyte growth factor as indicator for subclinical atherosclerosis

Article Link

Year:

2024

Impact of Age on Smartphone-Based Screening for Atrial Fibrillation: A Prespecified Subgroup Analysis of the eBRAVE-AF Trial

Article Link

Year:

2024

Angiotensin Receptor‐Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure

Article Link

Year:

2024

Inverse Correlation of Cholesterol Efflux Capacity with Peripheral Plaque Volume Measured by 3D Ultrasound

Article Link

Year:

2023

Smartwatch-derived heart rate variability: a head-to-head comparison with the gold standard in cardiovascular disease

Article Link

Year:

2023

Digital screening for atrial fibrillation ready for prime time? Lessons learned from eBRAVE‐AF

Article Link

Year:

2023

Increasing Soluble P-Selectin Levels Predict Higher Peripheral Atherosclerotic Plaque Progression

Article Link

Year:

2023

Letter from Austria

Article Link

Year:

2022

Long‐term effects of discontinuing renin–angiotensin system inhibitors in COVID‐19

Article Link

Year:

2022

Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an update.

Article Link

Year:

2022

Association of Food and Alcohol Consumption with Peripheral Atherosclerotic Plaque Volume as Measured by 3D-Ultrasound

Article Link

Year:

2020

NGAL Correlates with Femoral and Carotid Plaque Volume Assessed by Sonographic 3D Plaque Volumetry

Article Link

Year:

2020

Clinical evaluation of capillary B-type natriuretic peptide testing

Article Link

Year:

2020

Early onset of menopause is associated with increased peripheral atherosclerotic plaque volume and progression

Article Link

Year:

2020

Collaborators9

Silvia Felicetti

Medical University of Innsbruck

AUSTRIA

Felix Naegele

Medical University of Innsbruck

AUSTRIA

Leo Pölzl

Medical University of Innsbruck

AUSTRIA

Andreas Ritsch

Assistant Professor

AUSTRIA

Axel Bauer

Medical University of Innsbruck

AUSTRIA

Fiona R. Kolbinger

Research Assistant Professor

Purdue University

UNITED STATES

Monika Hunjadi

University of Natural Resources and Life Sciences

AUSTRIA

Peter Marschang

Medical University of Innsbruck

AUSTRIA

Fabian Theurl

AUSTRIA

How do I reach out?

Meet Kite AI